Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation
A Rohatiner
JCO Dec 1 1994: 2521–2523. [PDF]
The role of transplantation in non-Hodgkin's lymphoma
BA Peterson
JCO Dec 1 1994: 2524–2526. [PDF]
	Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies
	DL Darrington, JM Vose, JR Anderson, PJ Bierman, MR Bishop, WC Chan, ME Morris, EC Reed, WG Sanger, and SR Tarantolo
	JCO Dec 1 1994: 2527–2534. [Abstract] [PDF]
	Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma
	RM Stone, D Neuberg, R Soiffer, T Takvorian, M Whelan, SN Rabinowe, JC Aster, P Leavitt, P Mauch, and AS Freedman
	JCO Dec 1 1994: 2535–2542. [Abstract] [PDF]
	Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte
	C Haioun, E Lepage, C Gisselbrecht, B Coiffier, A Bosly, H Tilly, P Morel, C Nouvel, R Herbrecht, and MF D'Agay
	JCO Dec 1 1994: 2543–2551. [Abstract] [PDF]
	Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma
	SJ Horning, RS Negrin, JC Chao, GD Long, RT Hoppe, and KG Blume
	JCO Dec 1 1994: 2552–2558. [Abstract] [PDF]
	High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma
	CH Weaver, FB Petersen, FR Appelbaum, WI Bensinger, O Press, P Martin, B Sandmaier, HJ Deeg, JA Hansen, and M Brunvand
	JCO Dec 1 1994: 2559–2566. [Abstract] [PDF]
	Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy
	KC Marcus, LA Kalish, CN Coleman, LN Shulman, DS Rosenthal, GP Canellos, and PM Mauch
	JCO Dec 1 1994: 2567–2572. [Abstract] [PDF]
	Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy
	JA DiGiuseppe, WG Nelson, EJ Seifter, JK Boitnott, and RB Mann
	JCO Dec 1 1994: 2573–2579. [Abstract] [PDF]
	Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia
	C Sebban, E Lepage, JP Vernant, E Gluckman, M Attal, J Reiffers, L Sutton, E Racadot, M Michallet, and D Maraninchi
	JCO Dec 1 1994: 2580–2587. [Abstract] [PDF]
	The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype
	J Mercieca, E Matutes, C Dearden, K MacLennan, and D Catovsky
	JCO Dec 1 1994: 2588–2593. [Abstract] [PDF]
	Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report
	GS Gilchrist, DG Tubergen, HN Sather, PF Coccia, RT O'Brien, MJ Waskerwitz, and GD Hammond
	JCO Dec 1 1994: 2594–2600. [Abstract] [PDF]
	Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative
	CH Pui, SC Raimondi, ML Hancock, GK Rivera, RC Ribeiro, HH Mahmoud, JT Sandlund, WM Crist, and FG Behm
	JCO Dec 1 1994: 2601–2606. [Abstract] [PDF]
	Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age
	BH Kushner, MP LaQuaglia, MA Bonilla, K Lindsley, N Rosenfield, S Yeh, J Eddy, WL Gerald, G Heller, and NK Cheung
	JCO Dec 1 1994: 2607–2613. [Abstract] [PDF]
	Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy
	MD Tabone, C Kalifa, C Rodary, M Raquin, D Valteau-Couanet, and J Lemerle
	JCO Dec 1 1994: 2614–2620. [Abstract] [PDF]
	Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer
	RW Butler, JM Hill, PG Steinherz, PA Meyers, and JL Finlay
	JCO Dec 1 1994: 2621–2629. [Abstract] [PDF]
	Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis
	RL Foote, CL Loprinzi, AR Frank, JR O'Fallon, S Gulavita, HH Tewfik, MA Ryan, JM Earle, and P Novotny
	JCO Dec 1 1994: 2630–2633. [Abstract] [PDF]
	Detection of circulating tumor cells in men with localized prostate cancer
	MV Seiden, PW Kantoff, K Krithivas, K Propert, M Bryant, E Haltom, L Gaynes, I Kaplan, G Bubley, and W DeWolf
	JCO Dec 1 1994: 2634–2639. [Abstract] [PDF]
	The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
	PG Johnston, ER Fisher, HE Rockette, B Fisher, N Wolmark, JC Drake, BA Chabner, and CJ Allegra
	JCO Dec 1 1994: 2640–2647. [Abstract] [PDF]
	Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer
	GP Browman, C Cripps, DI Hodson, L Eapen, J Sathya, and MN Levine
	JCO Dec 1 1994: 2648–2653. [Abstract] [PDF]
	European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
	EA Eisenhauer, WW ten Bokkel Huinink, KD Swenerton, L Gianni, J Myles, ME van der Burg, I Kerr, JB Vermorken, K Buser, and N Colombo
	JCO Dec 1 1994: 2654–2666. [Abstract] [PDF]
	Dose-ranging study of recombinant human granulocyte-macrophage colony- stimulating factor in small-cell lung carcinoma
	J Hamm, JH Schiller, C Cuffie, M Oken, RI Fisher, F Shepherd, and G Kaiser
	JCO Dec 1 1994: 2667–2676. [Abstract] [PDF]
	Measurable or assessable disease in lung cancer trials: does it matter?
	JR Jett, JQ Su, JE Krook, RM Goldberg, and JW Kugler
	JCO Dec 1 1994: 2677–2681. [Abstract] [PDF]
	Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer
	H Choy, W Akerley, H Safran, J Clark, V Rege, A Papa, M Glantz, Y Puthawala, C Soderberg, and L Leone
	JCO Dec 1 1994: 2682–2686. [Abstract] [PDF]
	Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research
	G Cocconi, M Bella, S Zironi, R Algeri, F Di Costanzo, V De Lisi, G Luppi, B Mazzocchi, C Rodino, and M Soldani
	JCO Dec 1 1994: 2687–2693. [Abstract] [PDF]
	Primary therapy of Waldenstrom's macroglobulinemia with 2- chlorodeoxyadenosine
	MA Dimopoulos, H Kantarjian, D Weber, S O'Brien, E Estey, K Delasalle, E Rose, F Cabanillas, M Keating, and R Alexanian
	JCO Dec 1 1994: 2694–2698. [Abstract] [PDF]
	Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma
	P Picci, L Sangiorgi, BT Rougraff, JR Neff, R Casadei, and M Campanacci
	JCO Dec 1 1994: 2699–2705. [Abstract] [PDF]
	VAD-PECC regimen in the treatment of advanced-stage multiple myeloma
	M Delain, C Linassier, C Petitdidier, P Goupille, F Luthier, M Combe, M Reisenleiter, L Benboubker, JP Lamagnere, and P Colombat
	JCO Dec 1 1994: 2706–2713. [Abstract] [PDF]
	Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma
	AS Guleria, JC Yang, SL Topalian, JS Weber, DR Parkinson, MP MacFarlane, RL White, SM Steinberg, DE White, and JH Einhorn
	JCO Dec 1 1994: 2714–2722. [Abstract] [PDF]
	Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors
	TS Ravikumar, G Pizzorno, W Bodden, J Marsh, R Strair, J Pollack, R Hendler, J Hanna, and E D'Andrea
	JCO Dec 1 1994: 2723–2736. [Abstract] [PDF]
	Salvage surgery for chemorefractory gestational trophoblastic disease
	E Lehman, DM Gershenson, TW Burke, C Levenback, EG Silva, and M Morris
	JCO Dec 1 1994: 2737–2742. [Abstract] [PDF]
	Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study
	AA Miller, JB Hargis, RC Lilenbaum, SZ Fields, GL Rosner, and RL Schilsky
	JCO Dec 1 1994: 2743–2750. [Abstract] [PDF]
	Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity
	E Au, CL Loprinzi, M Dhodapkar, T Nelson, P Novotny, J Hammack, and J O'Fallon
	JCO Dec 1 1994: 2751–2755. [Abstract] [PDF]
	Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis
	E Eisenberg, CS Berkey, DB Carr, F Mosteller, and TC Chalmers
	JCO Dec 1 1994: 2756–2765. [Abstract] [PDF]
ESHAP chemotherapy for relapsed/refractory non-Hodgkin's lymphoma
JW Sweetenham and PW Johnson
JCO Dec 1 1994: 2766a. [PDF]
The International Index is not useful in the classification of low- grade lymphoma
A Aviles
JCO Dec 1 1994: 2766b–2768. [PDF]
Safety, pharmacokinetics, and pharmacodynamics of high-dose etoposide
TL Schwinghammer
JCO Dec 1 1994: 2768–2769. [PDF]
Actions speak louder than words
PR Walker
JCO Dec 1 1994: 2769–2770. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.